A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases

被引:177
作者
Barisoni, Laura
Schnaper, H. William
Kopp, Jeffrey B.
机构
[1] NYU, Sch Med, Dept Pathol, New York, NY USA
[2] Northwestern Univ, Sch Med, Feinberg Sch Med, Dept Pediat,Div Kidney Dis, Chicago, IL USA
[3] NIDDKD, Kidney Dis Sect, NIH, US Dept HHS, Bethesda, MD USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 2卷 / 03期
关键词
D O I
10.2215/CJN.04121206
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A spectrum of proteinuric glomerular diseases results from podocyte abnormalities. The understanding of these podocytopathies has greatly expanded in recent years, particularly with the discovery of more than a dozen genetic mutations that are associated with loss of podocyte functional integrity. It is apparent that classification of the podocytopathies on the basis of morphology alone is inadequate to capture fully the complexity of these disorders. Herein is proposed a taxonomy for the podocytopathies that classifies along two dimensions: Histopathology, including podocyte phenotype and glomerular morphology (minimal-change nephropathy, focal segmental glomerulosclerosis, diffuse mesangial sclerosis, and collapsing glomerulopathy), and etiology (idiopathic, genetic, and reactive forms). A more complete understanding of the similarities and differences among podocyte diseases will help the renal pathologist and the nephrologist communicate more effectively about the diagnosis; this in turn will help the nephrologist provide more accurate prognostic information and select the optimal therapy for these often problematic diseases. It is proposed that final diagnosis of the podocytopathies should result from close collaboration between renal pathologists and nephrologists and should whenever possible include three elements: Morphologic entity, etiologic form, and specific pathogenic mechanism or association.
引用
收藏
页码:529 / 542
页数:14
相关论文
共 88 条
[1]   Collapsing glomerulopathy [J].
Albaqumi, Mamdouh ;
Soos, Timothy J. ;
Barisoni, Laura ;
Nelson, Peter J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (10) :2854-2863
[3]   1Familial collapsing glomerulopathy: Clinical, pathological and immunogenetic features [J].
Avila-Casado, MC ;
Vargas-Alarcon, G ;
Soto, ME ;
Hernandez, G ;
Reyes, PA ;
Herrera-Acosta, J .
KIDNEY INTERNATIONAL, 2003, 63 (01) :233-239
[4]   Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder [J].
Badhwar, A ;
Berkovic, SF ;
Dowling, JP ;
Gonzales, M ;
Narayanan, S ;
Brodtmann, A ;
Berzen, L ;
Caviness, J ;
Trenkwalder, C ;
Winkelmann, J ;
Rivest, J ;
Lambert, M ;
Hernandez-Cossio, O ;
Carpenter, S ;
Andermann, F ;
Andermann, E .
BRAIN, 2004, 127 :2173-2182
[5]   Parietal podocytes in normal human glomeruli [J].
Bariety, Jean ;
Mandet, Chantal ;
Hill, Gary S. ;
Bruneval, Patrick .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (10) :2770-2780
[6]   Modulation of podocyte phenotype in collapsing glomerulopathies [J].
Barisoni, L ;
Kopp, JB .
MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 57 (04) :254-262
[7]  
Barisoni L, 1999, J AM SOC NEPHROL, V10, P51
[8]   Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies [J].
Barisoni, L ;
Mokrzycki, M ;
Sablay, L ;
Nagata, M ;
Yamase, H ;
Mundel, P .
KIDNEY INTERNATIONAL, 2000, 58 (01) :137-143
[9]  
BARNETT HL, 1978, PEDIATRIC KIDNEY DIS, P695
[10]   MINIMAL CHANGE NEPHROTIC SYNDROME - HISTOPATHOLOGY AND STEROID-RESPONSIVENESS [J].
BERNSTEIN, J ;
EDELMANN, CM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1982, 57 (11) :816-817